December 9, 2019
During the 61st American Society of Hematology (ASH) meeting in Orlando, US, Know AML were pleased to speak to Charles Craddock, Queen Elizabeth Hospital, Birmingham, UK. We asked Charles Craddock: How can we work to accelerate clinical trials so that more patients can access novel agents sooner? Charles Craddock discusses scientific advances such as genomic stratification to guide treatment pathways and the emergence of novel agents in the field of AML. He talks about enhancing and reforming clinical trials so that more patients have access to drugs as soon as possible.